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Abstract
Background: In a variety of animal species, hyperthermia in pregnancy has been recognized as teratogenic.
Hyperthermia interferes with protein synthesis via heat-shock proteins, which can entail membrane disruption,
cell death, vascular disruption, and placental infarction. This can induce severe fetal malformations or death. Fever
during pregnancy, especially during embryogenesis, has also been associated with congenital malformations in
human offspring.
The purpose of this large cohort study of clinically recognized pregnancies was to investigate whether fever during first
trimester was associated with an increased risk of congenital malformations in the offspring.
Methods: The Danish National Birth Cohort is a population-based cohort of 100,418 pregnant women and their
offspring recruited in 1996 to 2002. Information on fever during pregnancy was collected prospectively by means
of two telephone interviews.
The study population comprised the 77,344 pregnancies enrolled in the Danish National Birth Cohort where self-
reported information on fever during first trimester of pregnancy was available. Pregnancy outcomes were identified
through linkage with the National Patient Registry. Congenital malformations within the first three and a half years of
life were categorized according to EUROCAT’s classification criteria. Logistic regression models were used to estimate
the associations between fever in first trimester and overall congenital malformations and congenital malformations
by subgroups.
Results: Eight thousand three hundred twenty-one women reported fever during first trimester (10.8%) and 2876
infants were diagnosed with a congenital malformation (3.7%). Fever during first trimester did not affect the risk
of overall fetal congenital malformation (OR 0.99, 95% CI 0.88–1.12). The subgroup analyses indicated slightly
higher risk of congenital anomalies in the eye, ear, face and neck (OR 1.29, 95% CI 0.78–2.12) and in the genitals
(OR 1.17, 95% CI 0.79–1.12), whereas lower risk of malformations in the nervous system (OR 0.47, 95% CI 0.21–1.
08), the respiratory system (OR 0.56, 95% CI 0.23–1.29) and in the urinary subgroup (OR 0.58, 95% CI 0.35–0.99)
was suggested, the latter constituting the only statistically significant finding.
Conclusions: Overall, this study did not show any association between maternal fever in pregnancy and risk of
congenital anomalies.
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Background
Congenital malformations are in the top 20 of leading
causes of burden of disease globally [1] and are a signifi-
cant contributor to infant mortality with 11,3% of neonatal
deaths caused by congenital malformations [2]. Congenital
malformations may result in long-term disability and
thereby have significant impact on individuals, families,
health care systems, and societies [3]. Malformations may
have infectious, genetic or environmental origin but for
the majority the etiology remains unknown [2].
For several decades, hyperthermia in pregnancy has
been recognized as a teratogen in a variety of animal
species including guinea pigs, rats, mice, pigs, sheep, and
monkeys [4–6]. Hyperthermia interferes with protein
synthesis via heat-shock proteins, which can entail mem-
brane disruption, cell death, vascular disruption, and
placental infarction [7–10]. All these mechanisms can
induce severe fetal malformations or death.
Several case-control studies in human beings have
associated fever in pregnancy with among other neural
tube defects [11–14], cardiac malformations [15–18],
oral clefts [19, 20], and renal malformations [21]. The
nature of the specific malformations appears to depend
on the extent, duration and timing of maternal fever [7],
and it is therefore important to include information
about the timing of these febrile episodes.
In this study, we investigate the association between
fever in pregnancy and fetal congenital malformations in
a large population-based cohort. We focused on fever in
first trimester of pregnancy, when any teratogenic effect
on the fetus is most plausible to occur. We expected
more pronounced associations between fever and con-
genital anomalies the higher the temperature, the longer
the duration of the febrile incident and with the time of
fever during embryogenesis. Furthermore, we expected
the association between timing of fever episodes and the
different congenital malformation subgroups to vary due
to the timing of the organogenesis.
Methods
Study population
Data was obtained from the Danish National Birth Cohort
(DNBC), which is an ongoing population-based cohort of
100,418 pregnant women and their offspring recruited
between March 1996 and November 2002 [22].
General practitioners invited pregnant women to partici-
pate in the study at their first antenatal care visit. To be
able to participate in DNBC, the women had to: be preg-
nant, intend to carry their pregnancy to term, speak Danish
well enough to be interviewed by telephone in Danish, and
have a permanent address in Denmark. The women
consented to be interviewed twice during pregnancy and
allowed information concerning their own and their
offspring’s health to be obtained from national registries.
Of all the enrolled pregnancies (n = 100,418), those
that resulted in birth of live-born singletons (n = 92,670)
and where the woman had participated in both the first
(n = 86,783) and the second interview (n = 80,781) were
included in the study. Mother–infant pairs with more
than one week of discrepancy between the mother’s
report of gestational age in the two interviews (n = 1567)
were excluded as the information regarding timing of
fever were considered unreliable. Likewise, all mother-
infant pairs with incomplete information on fever (n = 919)
were excluded.
Incomplete information about any of the a priori
defined confounders: parity (0, 1, 2 or ≥3), previous spon-
taneous abortion (yes or no), maternal age at conception
(≤24, 25–29, 30–34 and ≥35), in vitro fertilization (yes or
no/irrelevant), maternal diabetes mellitus (yes or no) or
rheumatoid arthritis (yes or no), medical treatment of
epilepsy (yes or no), binge drinking, defined as drinking
five or more drinks at one occasion, during first trimester
of pregnancy (yes or no), smoking during pregnancy
(yes or no), and socio-occupational status (higher grade
professionals, lower grade professionals, skilled workers,
unskilled workers, students, and unemployed >1 year)
(n = 951) also resulted in an exclusion from the study.
The remaining 77,344 mother–infant pairs were included
in the analyses.
Exposure
In this study the exposure of interest was fever during
first trimester. Information about fever episodes was
obtained in the two computer-assisted telephone inter-
views, where the first interview was completed at a median
gestational age of 16 weeks (10th to 90th percentiles:
12–29 weeks) and the second at a median gestational
age of 31 weeks (10th to 90th percentiles: 28–36 weeks).
For the majority of women, information regarding fever
was acquired from the first interview. For 7026 women,
who participated in the first interview before the end of
the 12th gestational week, we also used information
about number and timing of fever episodes in the first
trimester from the second interview. In both interviews,
the women were asked about occurrence of fever, the
maximum temperature, the timing of the fever episodes,
the number of days with fever, and the number of fever
episodes. English translations of the interviews are avail-
able at www.dnbc.dk.
In the analyses of the intensity of fever exposure, the max-
imum temperature was categorized as below 39 °C, over
39 °C, or unknown. The rationale for this categorization
was based on literature showing that the teratogenic thresh-
old effect in many species begins approximately at 1.5 °C
above normal core body temperature [7].
Duration of fever was calculated as the longest period
of consecutive days with fever (1 day, 2–3 days, 4 days
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or more, or unknown) and the fever episodes were divided
into groups according to gestational age (pregnancy week
1–4, 5–8, and 9–12).
Outcome
Denmark has a Civil Registration System where all citizens
are registered with a unique 10-digit identification number
used in all registries to identify the person. The identifica-
tion numbers were used to link information from the
Danish National Patient Registry, where pregnancy
outcomes including information on congenital malfor-
mations were identified [23].
Congenital malformations in live-born children were
diagnosed by physicians according to the International
Classification of Disease 10th version (ICD-10), and all
children diagnosed with ICD-codes Q00.0 to Q99.9 during
the first three and a half year of life were identified.
The congenital malformations were divided into categor-
ies according to the classification criteria of the European
Surveillance of Congenital Anomalies (EUROCAT) as seen
in Table 3, where the ICD-10 codes are also specified [24].
Isolated minor congenital malformations (n = 1692)
were excluded as cases. According to EUROCAT,
minor congenital malformations are characterized as
malformations with lesser medical, functional or cosmetic
importance [24] .
A small group of infants with aneuploidy (n = 36) was
not included as cases, as this chromosomal anomaly is a
result of errors in mitosis or meiosis happening before
conception.
Some of the congenital malformation categories were
joined to form a broader group. The ear, face and neck
subgroup was pooled with the eye subgroup and the
musculo-skeletal- and limb categories were also united.
Finally, in addition to the ICD-10 codes defined by
EUROCAT, the category “Other” included the subgroups
with abdominal malformations and the chromosomal
malformations other than aneuploidies.
Children with more than one malformation were in-
cluded in each appropriate anomaly subgroup, but were
only counted once in the “Overall malformations” group.
Covariates
Information on several covariates was obtained for
main- and sub analyses (see Table 1). Information on the
majority of the covariates was derived from the first
interview, with the exception of medical treatment of
epilepsy, use of antipyretics, and maternal infections,
which was derived from the second interview.
Socio-occupational status was the household com-
bined socio-occupational status, defined by the highest
status within the couple. The information on maternal
pre-diabetes mellitus was based on a combination of
self-report and data from the National Patient Registry
and this variable did not distinguish between Type I and
Type II diabetes. Pre-conceptional intake of folic acid
was self-reported at the time of recruitment to the
cohort, and child sex came from the Civil Registration
System. Maternal infections encompassed; urinary tract
infections, vaginal infections, respiratory tract infections,
gastroenteritis and childhood diseases.
Statistical analysis
The associations between fever in the first trimester of
pregnancy and 1) all congenital malformations and 2)
congenital malformations by subgroups were estimated
as odds ratios (OR) using logistic regression. The esti-
mated ORs were presented with 95% confidence intervals
(CI). Crude and adjusted analyses were performed and the
a priori defined covariates were included in the adjusted
analyses.
Some of the children in the cohort were born to the
same mother and to take this into account we estimated
95% CI using robust standard errors.
Sub analyses
To consider the influence of maternal infections during
first trimester and use of antipyretics in first trimester
on the estimated relationships, a first degree interaction
between fever in first trimester, maternal infections and
antipyretic use, respectively, was evaluated for overall
congenital malformations using a Wald test.
Furthermore, the association between various measures
of fever in first trimester (presented in Table 2) and overall
congenital malformations was estimated while further
adjusting for maternal infections in first trimester. Also,
stratified analyses of the association between various
measures of fever in first trimester and overall con-
genital malformations according to antipyretic use in
the first trimester were performed.
Results
In total 2876 children of 77,344 live-born singletons in
this study were diagnosed with a congenital malforma-
tion before the age of three and a half years. The overall
malformation prevalence in the study population was
3.7%, and this figure was higher for offspring of mothers
with diabetes mellitus (PP = 6.5%), rheumatoid arthritis
(PP = 8.9%), and offspring of women receiving medical
treatment for epilepsy (PP = 9.4%),
Overall, 46.6% of the mothers were nulliparas while
37.3% had given birth once before. However, in the
subgroup of women with fever in first trimester only
40.6% were nulliparas while 42.1% were primiparas,
Table 1.
Overall, 8321 (10.8%) women reported at least one
episode of fever within the first 12 weeks of pregnancy.
Of the women reporting fever, only 62,2% reported the
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Table 1 Characteristics of the 77,344 women with live-born singletons according to maternal fever in 1st trimester
Total Fever in 1st trimester No fever in 1st trimester
N % PPa N % N %
Total study population 77,344 100 3.7 8321 100 69,023 100
Parity
0 36,017 46.6 4.1 3375 40.6 32,642 47.3
1 28,843 37.3 3.4 3502 42.1 25,341 36.7
2 10,159 13.1 3.4 1191 14.3 8968 13.0
≥ 3 2325 3.0 3.2 253 3.0 2072 3.0
Previous spontaneous abortion
No 62,570 80.9 3.7 6646 79.9 55,924 81.0
Yes 14,774 19.1 3.8 1675 20.1 13,099 19.0
Maternal age at conception
≤ 24 9656 12.5 3.7 1012 12.2 8644 12.5
25–29 32,370 41.9 3.8 3477 41.8 28,893 41.9
30–34 26,466 34.2 3.7 2940 35.3 23,526 34.1
≥ 35 8852 11.4 3.6 892 10.7 7960 11.5
In Vitro Fertilization
No/Irrelevant 75,646 97.8 3.7 8178 98.3 67,468 97.8
Yes 1698 2.2 4.7 143 1.7 1555 2.3
Maternal diabetes
No 77,127 99.7 3.7 8285 99.6 68,842 99.7
Yes 217 0.3 6.5 36 0.4 181 0.3
Medical treatment of maternal epilepsy
No 77,120 99.7 3.7 8306 99.8 68,814 99.7
Yes 224 0.3 9.4 15 0.2 209 0.3
Maternal rheumatoid arthritis
No 77,243 99.9 3.7 8312 99.9 68,931 99.9
Yes 101 0.1 8.9 9 0.1 92 0.1
Binge drinking in 1st trimester
No 59,006 76.3 3.7 6218 74.7 52,788 76.5
Yes 18,338 23.7 3.8 2103 25.3 16,235 23.5
Smoking during pregnancy
No 57,719 74.6 3.7 6116 73.5 51,603 74.8
Yes 19,625 25.4 3.8 2205 26.5 17,420 25.2
Socio-occupational status
Higher grade professionals 18,443 23.9 3.7 2118 25.5 16,325 23.7
Lower grade professionals 24,247 31.4 3.6 2716 32.6 21,531 31.2
Skilled workers 21,635 28.0 3.9 2127 25.6 19,508 28.3
Unskilled workers 10,697 13.8 3.6 1084 13.0 9613 13.9
Students 1782 2.3 4.3 217 2.6 1565 2.3
Unemployed >1 year 540 0.7 4.3 59 0.7 481 0.7
Child sex
Male 39,546 51.1 4.0 4211 50.6 35,335 51.2
Female 37,798 48.9 3.5 4110 49.4 33,688 48.8
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maximum temperature and of these almost half (49,5%)
reported fever incidents with a temperature of 39 °C or
more. In contrast, almost all women provided informa-
tion about the duration of the fever incident and the dis-
tribution can be seen in Table 2.
The analyses revealed no increased risk of overall con-
genital malformations when the exposure was fever at
any point during first trimester of pregnancy (OR 0.99,
95% CI 0.88–1.12). The risk of congenital malformations
was slightly higher if the fever episode occurred during
Table 1 Characteristics of the 77,344 women with live-born singletons according to maternal fever in 1st trimester (Continued)
Total Fever in 1st trimester No fever in 1st trimester
N % PPa N % N %
Pre-conceptional intake of folic acid
No 67,892 87.8 3.7 7283 87.5 60,609 87.8
Yes 9353 12.1 3.8 1029 12.4 8324 12.1
Total 77,245 99.9 3.7 8312 99.9 68,933 99.9
Missing 99 0.1 3.0 9 0.1 90 0.1
Antipyretic use in 1st trimester
No 65,205 84.3 3.8 6558 78.8 58,647 85.0
Yes 11,982 15.5 3.5 1748 21.0 10,234 14.8
Missing 157 0.2 4.5 15 0.2 142 0.2
Infections in 1st trimester
No 64,164 83.0 3.7 6012 72.2 58,152 84.3
Yes 12,145 15.7 3.8 2196 26.4 9949 14.4
Missing 1035 1.3 3.2 113 1.4 922 1.3
The Danish National Birth Cohort 1996–2002
aPP: Prevalence Proportion of overall congenital malformations per 100 live births




OR Crude [95% CI]
Congenital Malformations
Adjusted* OR [95% CI]
Fever
No 69,023 2574 1 [Ref] 1 [Ref]
Yes 8321 302 0.97 [0.86–1.10] 0.99 [0.88 1.12]
Gestational age at fever incidents
No fever 69,023 2574 1 [Ref] 1 [Ref]
Pregnancy week 1–4 1032 43 1.12 [0.82–1.52] 1.13 [0.83–1.54]
Pregnancy week 5–8 3407 124 0.98 [0.81–1.17] 0.99 [0.83–1.19]
Pregnancy week 9–12 3882 135 0.93 [0.78–1.11] 0.95 [0.79–1.13]
Maximum temperature
No fever 69,023 2574 1 [Ref] 1 [Ref]
< 39.0 ° C 2613 108 1.11 [0.91–1.35] 1.12 [0.91–1.36]
≥ 39.0 ° C 2562 98 1.03 [0.84–1.26] 1.06 [0.86–1.30]
Unknown 3146 96 0.81 [0.66–1.00] 0.82 [0.67–1.01]
Duration of fever episode
No fever 69,023 2574 1 [Ref] 1 [Ref]
1 day 1647 55 0.89 [0.68–1.17] 0.90 [0.69–1.18]
2–3 days 4799 180 1.01 [0.86–1.17] 1.02 [0.88–1.19]
+ 4 days 1873 67 0.96 [0.75–1.23] 0.98 [0.76–1.25]
Unknown 2 0 .. ..
The Danish National Birth Cohort 1996–2002
*Adjusted for parity, previous spontaneous abortion, maternal age at conception, IVF, diabetes mellitus, medical treatment of maternal epilepsy, rheumatoid
arthritis, binge drinking in first trimester, smoking during pregnancy, and socio-occupational status
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the 1–4 gestational week (OR 1.13, 95% CI 0.83–1.54),
though not statistically significant. The estimates for the
other gestational periods were not associated with in-
creased risk of congenital malformations and the same
accounts for the intensity of fever and the number of
days with fever, Table 2.
Sub analyses
Wald test showed no sign of interaction between fever
in first trimester and maternal infections and antipyretic
use, respectively (p-value = 0.95; p-value = 0.20). None of
the estimates for the relationship between the various
measures of fever in first trimester and overall congenital
malformations as presented in Table 2 changed appre-
ciably when further adjusting for maternal infections in
first trimester or in the analyses stratified according to the
use of antipyretics in first trimester (results not shown).
In relation to the subgroups of congenital malforma-
tions, fever during first trimester was associated with
slightly increased risk of congenital malformations in the
eye, ear, face and neck (OR 1.29, 95% CI 0.78–2.12) and in
the genitals (OR 1.17, 95% CI 0.79–1.71), however, none
of them statistically significant. Furthermore, a decreased
risk of congenital malformations was seen in the following
categories: nervous system (OR 0.47, 95% CI 0.21–1.08),
urinary tract (OR 0.58, 95% CI 0.35–0.99) and respiratory
system (OR 0.56, 95% CI 0.23–1.29). Of these, only the
decreased risk of urinary tract congenital malformations
was statistically significant. The remaining subgroups of
congenital malformations were not associated with
exposure to fever during first trimester of pregnancy,
Table 3.
Discussion
In this large cohort study, fever during first trimester of
pregnancy was not significantly associated with congeni-
tal malformations diagnosed within the child’s first three
and a half years of life. The analyses demonstrated that
there are no statistically significant association between
fever in first trimester and any of the congenital malfor-
mation subgroups, except for a decreased risk of
malformations in the urinary system. The reduced risk,
although statistically insignificant, of having a congenital
malformation in the nervous system is unexpected consid-
ering results from previous studies where central nervous
system defects are among the most common consequences
of hyperthermia [7, 11, 13, 25–29]. Since most malforma-
tions in the nervous system are extremely severe, a possible
explanation might be that many of the fetuses with
malformations in the nervous system were aborted
before recognition of pregnancy or before the first ante-
natal care visit at the general practitioner and thereby
before a possible enrollment into the DNBC.
A previous study reported that fever in the first
16 weeks of pregnancy did not increase the risk of spon-
taneous abortions in clinically recognized pregnancies in
this cohort [8], and thus it seems unlikely that these




Fever in 1st Trimester
OR [95% CI]
ADJUSTEDa OR
Fever in 1st Trimester
OR [95% CI]
Type of Congenital Malformation
Overall Malformationsb 2876 0.97 [0.86–1.10] 0.99 [0.88–1.12]
Nervous system (DQ00 – DQ07) 114 0.46 [0.20–1.05] 0.47 [0.21–1.08]
Eye, ear, face and neck (DQ10 – DQ18) 134 1.29 [0.78–2.12] 1.29 [0.79–2.10]
Congenital heart defects (DQ20 – DQ26) 656 0.99 [0.77–1.27] 1.01 [0.79–1.29]
Respiratory system (DQ30 – DQ34) 79 0.56 [0.23–1.39] 0.56 [0.23–1.39]
Orofacial clefts (DQ35 – DQ37) 163 0.90 [0.54–1.51] 0.90 [0.54–1.50]
Digestive system (DQ38 – DQ45, DQ790) 198 0.98 [0.63–1.55] 1.00 [0.63–1.56]
Genital (DQ50 – DQ52,DQ54 – DQ56) 249 1.14 [0.78–1.67] 1.17 [0.79–1.71]
Urinary (DQ60 – DQ64,DQ794) 231 0.58 [0.34–0.97] 0.58 [0.35–0.99]
Limb and musculoskeletal (DQ650-DQ652,DQ58-DQ660,
DQ681-DQ682, DQ688, DQ69 – DQ75, DQ761-DQ764,
DQ766-DQ769, DQ77-DQ78, DQ796, DQ798-DQ799)
1157 1.04 [0.87–1.25] 1.06 [0.88–1.28]
Other (DQ27-DQ28, DQ80-DQ85, DQ87, DQ89, DQ93,
DQ99, DQ792, DQ793,DQ795)
297 1.00 [0.69–1.45] 1.01 [0.70–1.46]
Classification of malformations with ICD-10 codes derived from EUROCAT
The Danish National Birth Cohort 1996–2002
aAdjusted for parity, spontaneous abortion, maternal age at conception, IVF, diabetes Mellitus, medical treatment of maternal epilepsy, rheumatoid arthritis, binge
drinking in first trimester, smoking during pregnancy and socio-occupational status
bCases with more than one malformation are only counted once in the “Overall malformations” subgroup
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congenital malformations resulted in spontaneous abor-
tions at a later state in pregnancy.
During the study period, women over 35 years and
women at high risk of having a child with congenital
malformations were offered prenatal screening [22].
Hence, another feasible explanation of the decreased risk
of having a child with malformations in the nervous
system could be that the women, who had an ultrasonic
examination diagnosing the fetus with severe malforma-
tions in the nervous system, subsequently had an induced
abortion. Since the study population only includes live-
born singletons, it is not possible to rule out that induced
abortions could help explain the decreased risk of malfor-
mations in the nervous system. In order to address this
question, we estimated the risk of induced abortion due to
fetal disease among the women in the DNBC who partici-
pated in the first interview after week 12 (n = 82,003). The
analysis indicated an increased risk of termination of
pregnancy due to fetal abnormality (OR 1.56, 95% CI
0.96–2.55) if the women had fever during first trimester
of pregnancy. Hence, this might partly explain the unex-
pected finding regarding nervous system anomalies.
The identification of a statistically significant reduced
risk of giving birth to a child with urinary congenital
malformations after having fever during first trimester of
pregnancy found in this study does not correspond to
the findings in a previous study [21]. However, as a
number of statistical tests were conducted on the same
overall study population this may be a chance finding
and thus the result of a statistical type 1 error.
Previous studies on maternal fever and congenital
malformations have reported different results. This
inconsistency may be caused by differences in one or more
study factors including the method used for measuring
body temperature, duration and timing of fever episodes,
recall bias in retrospective studies, small study sizes, and
confounding.
Generally, participation rates in large cohort studies
have diminished over the last decades to around the
level observed in DNBC, where approximately 60% of
the invited pregnant women in Denmark participated
[22]. Because of the relatively low participation rate in
the DNBC, selection bias is a possibility. The enrolled
women have previously been observed to be slightly
healthier overall than women in the source population;
nevertheless, this have been shown to have very limited
impact on risk estimates in DNBC [30], and the complete
register-based follow-up of the cohort furthermore pro-
tects against selection bias.
Nonetheless, selection may still be the reason why a
marginally lower proportion of overall congenital mal-
formations is seen in our cohort when compared to the
background population during the same time period
[31]. In our cohort, the proportion of children diagnosed
with a congenital malformation (including minor malfor-
mations) was 6% compared to 6.5% in the background
population.
Higher socioeconomic profile and healthier life style are
presumed to explain these differences, as women enrolled
in cohorts have been shown to be healthier and more
well-off [31–34]. Thus cohorts are selected samples,
but baseline-selection is by definition independent of
outcome and thereby does not introduce selection bias in
the exposure-outcome association. However, baseline-
selection may impact the confounding pattern, thus it is
different from the source population of each cohort [35].
Strengths of the present study include the large sample
size, the prospectively collected information on fever, the
detailed information on body temperature, duration and
timing of fever episodes, the nearly complete follow-up
and the adjustment for a variety of covariates. Further-
more, since all confidence intervals in this study are
relatively narrow the accuracy of the estimate is high.
A limitation in this study was that, like most studies on
birth anomalies, only live-born children were included,
since congenital malformations in stillbirths, spontaneous
abortions and medically terminated pregnancies are not
registered in Denmark.
Additionally, the relatively limited number of children
with congenital anomalies in this study did not allow us to
stratify the outcome further than the overall groups of
congenital malformations recommended by EUROCAT.
This lumping of specific malformations into body system
groups might have masked slightly increased risk of the
rarest malformations.
Information on fever in first trimester was collected
prospectively, i.e. before pregnancy outcome was known,
and thus any misclassification of exposure was non-
differential, leading to an underestimation of the associ-
ation. The lacking information on how body temperature
was measured imparts an uncertainty to the data regarding
temperature. Nonetheless, body temperature was (in the
times of the data collection) usually measured with a rectal
thermometer and the temperature information indicated
can therefore likely be regarded as a measure of core
temperature [8]. Additionally, the maximum temperature
is not necessarily the correct maximum temperature for
the event but the highest value measured.
The overall validity of data on diagnoses from the
National Patient Registry is considered to be acceptable
for general surveillance and epidemiological research [35],
also when specifically considering congenital malforma-
tions [32]. Children diagnosed with a congenital malforma-
tion until the age of three and a half years were included in
the study, and this period ensured that the majority of
congenital malformations usually not detected at birth
were also included. However, uncertainty and inaccuracies
in the diagnoses are still seen in national registries, but
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incorrect diagnoses can at most lead to non-differential
misclassification, which would result in an underestimation
of the association.
Conclusions
While most case-control studies indicate positive associ-
ations between maternal fever and selected congenital
anomalies, the results of this large-scale cohort study do
not support a relation between maternal fever during
first trimester of pregnancy and congenital anomalies.
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